Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Scioto1on Jul 23, 2021 7:12am
112 Views
Post# 33595022

RE:RE:It must continue to press the same Management issues

RE:RE:It must continue to press the same Management issues
Sure, overtime there have been some good decisions, but I think it's fair to say that shareholder has not been enhanced, sound decision making, with the interest of existing shareholders was absent with the last financing, and investor communication and promotions have been lacking. The three items I identified should be top of mind for all growing companies: (1) Relentless efforts to recruit and support board members that enhance leadership, (2) acknowledging and promoting stock ownership by board members, (3) developing a comprehensive investor recruitment and relations effort with accountability measures --- all would enhance shareholder value efforts. These are the things we can push, year round, to give the CEO the support he needs and set the expectations for enhancing shareholder value.
<< Previous
Bullboard Posts
Next >>